---
title: "Managing serotonin toxicity: recognition and treatment essentials"
id: "cmaj-3-managing-serotonin-toxicity-practice"
canonical_url: "https://medichelpline.com/clinical-feed/cmaj-3-managing-serotonin-toxicity-practice"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "CMAJ"
source_url: "http://www.cmaj.ca/cgi/content/short/198/29/E1158?rss=1"
published_at: "2026-08-24T04:05:24.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Managing serotonin toxicity: recognition and treatment essentials
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/cmaj-3-managing-serotonin-toxicity-practice
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** CMAJ
- **Source URL:** [Original Journal Publication](http://www.cmaj.ca/cgi/content/short/198/29/E1158?rss=1)
- **Published At:** 2026-08-24T04:05:24.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- Serotonin toxicity (also known as **serotonin syndrome**) is a potentially life‑threatening reaction caused by acute excessive serotonergic activity at 5‑HT1A and 5‑HT2A receptors after starting or increasing a serotonergic agent, overdose, or drug–drug interactions. - Clinical severity ranges from mild agitation to inducible clonus, autonomic hyperactivity, hyperthermia and delirium; diagnosis is clinical and may be guided by the **Hunter criteria** derived from seven variables (spontaneous, inducible, and ocular clonus; agitation; diaphoresis; tremor; hyperreflexia). - Approximately 15% of SSRI overdoses result in serotonin toxicity, independent of ingested dose. Age and sex do not alter risk; coingestion of a monoamine oxidase inhibitor increases risk about fivefold. - **Hyperthermia** from serotonin toxicity is a medical emergency; severe rigidity and impaired thermoregulation can rapidly cause rhabdomyolysis, disseminated intravascular coagulation, multiorgan failure and death. - Active cooling, including ice water immersion when appropriate, is critical; if temperature cannot be reduced below 39°C quickly, paralysis and intubation may be necessary. - All serotonergic medications should be discontinued when serotonin toxicity is suspected. Commonly implicated agents include SSRIs, tricyclic antidepressants and tramadol; other often‑overlooked agents include lithium, St. John’s wort, methadone, fentanyl and methylene blue. - Supportive care and **benzodiazepines** are the mainstay of treatment. In mild cases, stopping the offending drug may suffice; in more severe cases, rapid escalation of benzodiazepines and intravenous fluids is essential to control agitation, sympathetic overactivity and muscle hyperactivity. - Serotonin antagonists such as **cyproheptadine** can be used as adjunctive treatment in moderate cases, though evidence is limited and high initial doses may be required. Other antagonists include chlorpromazine and olanzapine. - Clinicians should consult regional poison centres or medical toxicologists for guidance on diagnosis and management. - The article emphasizes early recognition, prompt discontinuation of serotonergic agents, aggressive supportive measures for autonomic and neuromuscular symptoms, and escalation to specific antagonists or advanced airway and paralysis when indicated.
## Clinical Analysis & Structured Key Points
Managing serotonin toxicity | CMAJ Skip to main content Log in Toggle navigation menu Open settings menu Open search Advanced Search Advanced Search Log in --> Managing serotonin toxicity Ian V. Beamish Ian V. Beamish Department of Medicine (Beamish), Division of Emergency Medicine; Department of Medicine (Austin, Kent), Divisions of Emergency Medicine and Clinical Pharmacology & Toxicology, University of Toronto; Department of Emergency Medicine (Austin, Kent), St. Michael’s Hospital; Ontario Poison Centre (Austin, Kent), Toronto, Ont. MD Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emily Austin Emily Austin Department of Medicine (Beamish), Division of Emergency Medicine; Department of Medicine (Austin, Kent), Divisions of Emergency Medicine and Clinical Pharmacology & Toxicology, University of Toronto; Department of Emergency Medicine (Austin, Kent), St. Michael’s Hospital; Ontario Poison Centre (Austin, Kent), Toronto, Ont. MD Find this author on Google Scholar Find this author on PubMed Search for this author on this site and Jessica T. Kent Jessica T. Kent Department of Medicine (Beamish), Division of Emergency Medicine; Department of Medicine (Austin, Kent), Divisions of Emergency Medicine and Clinical Pharmacology & Toxicology, University of Toronto; Department of Emergency Medicine (Austin, Kent), St. Michael’s Hospital; Ontario Poison Centre (Austin, Kent), Toronto, Ont. MD MClSc Find this author on Google Scholar Find this author on PubMed Search for this author on this site CMAJ August 24, 2026 198 (29) E1158; DOI: https://doi.org/10.1503/cmaj.260159 PDF Help Article Related Content Responses Metrics PDF Serotonin toxicity is a potentially life-threatening adverse reaction to serotonergic agents Also called serotonin syndrome, the condition results from acute, excessive serotonergic activity at serotonin receptors (5-hydroxytryptamine 1A and 2A) following initiation or dose escalation of a serotonergic agent, overdose, or through drug–drug interactions. 1 Clinical presentation spans a spectrum from mild agitation to inducible clonus, autonomic hyperactivity, hyperthermia and delirium. 2 Although the true incidence is unknown, approximately 15% of overdoses from selective serotonin reuptake inhibitors (SSRIs) result in serotonin toxicity, independent of dose ingested. 1 Age and sex do not affect risk; however, coingestion of a monoamine oxidase inhibitor increases risk fivefold. 3 Diagnosis is clinical and may be guided by the Hunter criteria, which were derived from 7 variables (spontaneous, inducible, and ocular clonus; agitation; diaphoresis; tremor; hyperreflexia) (Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.260159/tab-related-content ). 1 , 4 Hyperthermia in serotonin toxicity is a medical emergency Although rare, severe muscle rigidity and impaired thermoregulation can rapidly lead to rhabdomyolysis, disseminated intravascular coagulation, multiorgan failure, and death. 1 Cooling with ice water immersion or other active measures is critical. 1 , 2 If the patient’s temperature cannot quickly be reduced to less than 39°C, paralysis and intubation may be necessary. 1 All serotonergic medications should be discontinued Commonly involved agents include SSRIs, tricyclic antidepressants, and tramadol, 5 as well as often-overlooked agents such as lithium, St. John’s wort, methadone, fentanyl, or methylene blue. Supportive care and benzodiazepines are the mainstay of treatment In mild cases, discontinuation of the causative agent may be sufficient. 1 In more severe cases, benzodiazepines are essential to decrease sympathetic outflow and muscle hyperactivity. Rapid dose escalation of benzodiazepines and intravenous fluids may be required to normalize vital signs and control agitation. 1 , 5 Serotonin antagonists may play a role in treatment of moderate-to-severe serotonin toxicity Cyproheptadine may be used as an adjunct to benzodiazepines in moderate cases, although evidence is limited and high initial doses may be required. 1 Other serotonin antagonists include chlorpromazine and olanzapine. 1 Clinicians should consult with a regional poison centre or medical toxicologist. CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at https://mc.manuscriptcentral.com/cmaj . Footnotes Competing interests: Emily Austin reports an honorarium from Toronto Metropolitan University. Jessica Kent reports funding from PSI Foundation and payment for expert testimony, outside the submitted work. No other competing interests were declared. This article has been peer reviewed. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ References 1 ↵ Chiew AL Isbister GK . Management of serotonin syndrome (toxicity) . Br J Clin Pharmacol 2025 ; 91 : 654 – 61 . Google Scholar OpenURL PubMed 2 ↵ Scotton WJ Hill LJ Williams AC . Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions . Int J Tryptophan Res 2019 Sept . 9 : 12 : 1178646919873925 . Google Scholar OpenURL PubMed 3 ↵ Cooper J Duffull SB Isbister GK . Predicting serotonin toxicity in serotonin reuptake inhibitor overdose . Clin Toxicol (Phila) 2023 ; 61 : 22 – 88 . Google Scholar OpenURL PubMed 4 ↵ Dunkley EJ Isbister GK Sibbritt D . The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity . QJM 2003 ; 96 : 635 – 42 . Google Scholar OpenURL CrossRef PubMed Web of Science 5 ↵ Mikkelsen N Damkier P Pedersen SA . Serotonin syndrome — a focused review . Basic Clin Pharmacol Toxicol 2023 ; 133 : 124 – 9 . Google Scholar OpenURL PubMed PDF Previous Next Back to top In This Issue CMAJ Vol. 198, Issue 29 24 Aug 2026 Table of Contents Index by author Article tools Respond to this article Print Download PDF Article Alerts Alerts for this Article User Name * Password * To sign up for email alerts or to access your current email alerts, enter your email address below: Email * Email Article Email This Article Thank you for your interest in spreading the word on CMAJ. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Managing serotonin toxicity Message Subject (Your Name) has sent you a message from CMAJ Message Body (Your Name) thought you would like to see the CMAJ web site. Your Personal Message CAPTCHA Please verify that you are a real person Close Citation Tools Citation Tools Managing serotonin toxicity Ian V. Beamish Ian V. Beamish Emily Austin Emily Austin and Jessica T. Kent Jessica T. Kent CMAJ Aug 2026, 198 (29) E1158; DOI: 10.1503/cmaj.260159 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Request Permissions Share Share This Article Managing serotonin toxicity Ian V. Beamish Ian V. Beamish Emily Austin Emily Austin and Jessica T. Kent Jessica T. Kent CMAJ Aug 2026, 198 (29) E1158; DOI: 10.1503/cmaj.260159 Share This Article: Copy Post Like 0 Jump To Section Serotonin toxicity is a potentially life-threatening adverse reaction to serotonergic agents Hyperthermia in serotonin toxicity is a medical emergency All serotonergic medications should be discontinued Supportive care and benzodiazepines are the mainstay of treatment Serotonin antagonists may play a role in treatment of moderate-to-severe serotonin toxicity Footnotes References PDF Related Articles No related articles found. Google Scholar PubMed Cited By... No citing articles found. Google Scholar More in this TOC Section A 38-year-old woman with tinea incognito Undiagnosed type 2 diabetes presenting as diabetic ketoacidosis with hypertriglyceridemia-induced acute pancreatitis A 58-year-old patient with right-sided weakness and a history of stroke Telemetry monitoring for patients admitted to hospital Complex dorsal metacarpophalangeal joint dislocation in a 15-year-old boy Show more Practice Similar Articles Serotonin: a review Isopropanol toxicity Diagnosis and management of toxicity associated with the recreational use of nitrous oxide Serotonin syndrome: not a benign toxidrome Suicide linked to serotonin gene See More View all jobs > (this link will open in a new window) Post a job > (this link will open in a new window) Latest Jobs General Practitioner Oncology Newfoundland & Labrador Academic Paediatric Clinician Investigator in Acquired Brain Injury Toronto, Ontario Assistant Dean, Admissions Surrey, British Columbia Freeman Family Chair and Medical Director North York, Ontario Cardiologist Kamloops, British Columbia Chair/Department Head, Department of Anesthesia & Perioperative Medicine London, Ontario
## Related Clinical Research

- [PCOS and Risk of Progression to Pre‑Diabetes and Diabetes: A Multistate Modeling Analysis](https://medichelpline.com/clinical-feed/pubmed-42659541.md) (DOI: 10.1002/edm2.70322)
- [Scalp acupuncture mechanisms regulating inflammation in vascular cognitive impairment](https://medichelpline.com/clinical-feed/pubmed-42621720.md) (DOI: 10.13702/j.1000-0607.20250874)
- [Pharma Friday: FDA OKs Rasonque for Metastatic Pancreatic Cancer and Mounjaro CV Approval — Sept 4](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-september-4-2026.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)
- [Framework for Assessing Cardiovascular Risk and Fitness for Duty in Tactical Athletes](https://medichelpline.com/clinical-feed/aha-news-0-new-guidance-introduces-framework-for-assessing-cardiovascular-risk-and-fitness.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.